Authored By: Sarah
18 Sep 2024

Latest News: High-Performance Liquid Chromatography (Hplc) Market is expected to grow by a CAGR of 6.09% during 2024-2028; Trends and Forecasts to 2018

The High-Performance Liquid Chromatography (Hplc) Market is expected to grow at a CAGR of 6.09% to reach USD 1565.8 million by 2028. The High-Performance Liquid Chromatography (HPLC) market is witnessing significant growth due to its widespread adoption in various sectors. In the healthcare industry, HPLC plays a pivotal role in clinical diagnosis, enabling the identification of alterations in endocrine and exocrine gland secretions for effective treatment of medical disorders. In the pharmaceutical industry, HPLC is a crucial tool for quality control, ensuring compliance with regulatory standards for manufactured products. Additionally, HPLC is indispensable for researchers in the fields of bioavailability studies, drug formulations, and dissolution testing.

North America dominates the regional market because of The High-Performance Liquid Chromatography (HPLC) market witnesses significant growth due to its widespread application in various industries, including pharmaceuticals, food and beverage, and chemical manufacturing. HPLC's ability to separate, identify, and quantify complex mixtures with high resolution and efficiency makes it an indispensable tool for quality control and research and development. Market trends include the development of advanced technologies, such as ultra-performance liquid chromatography (UPLC) and hyphenated techniques, to enhance analytical capabilities and productivity. The market is expected to continue its robust growth trajectory, driven by increasing demand for accurate and reliable analytical solutions.

There are various factors that drive the High-Performance Liquid Chromatography (Hplc) Market market which are as following: In the healthcare sector, prominent investors, including pharmaceutical companies such as Sun Pharmaceutical and Cipla Ltd, biotech firms, and the National Institutes of Health (NIH), are dedicating substantial resources towards advanced research and development. This investment is geared towards introducing innovative technologies in High-Performance Liquid Chromatography (HPLC) to bolster the healthcare industry's growth. Pharmaceutical firms are increasingly utilizing HPLC for sample testing and analysis to discover potential drug ingredients. Given the stringent regulatory requirements set by the US Food and Drug Administration (FDA), companies are prioritizing HPLC to ensure product quality before commercialization. This technology's adoption is essential for pharmaceutical firms to meet regulatory standards and deliver high-quality, effective medications to consumers.

Be the first one to get the industry updates. Request for a sample report

High-Performance Liquid Chromatography (Hplc) Market Segmentation

  • Product
    • Instruments
    • Consumables
    • Accessories
  • End-user
    • Pharmaceutical and biotechnology companies
    • Academic and research institutions
    • Others
  • Geography
    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

The market witnesses several challenges, which are as follows In the realm of advanced analytical technologies, High-Performance Liquid Chromatography (HPLC) instruments have emerged as indispensable tools for research and development in various industries. These sophisticated instruments offer unparalleled separation and analysis capabilities. However, their adoption is not without challenges, particularly for small research laboratories due to their high cost. For instance, the Agilent 1290 UHPLC Infinity DAD System and Agilent 1200 Preparative HPLC System, priced at USD39,500 and USD39,000 respectively, are out of reach for many research institutes. Similarly, the Thermo Scientific Dionex Ultimate 3000 UHPLC PREP System is priced at USD23,000. The Waters Alliance 2695 HPLC Separations Module (ELS 2420) System and Waters Alliance 2790 HPLC Separations Module with 996 PDA Detector are comparatively more affordable, priced at USD14,900 and USD11,999, respectively. Despite their significant benefits, the high cost of HPLC instruments remains a barrier to entry for several organizations, limiting their potential applications and advancements in research and development.

Stay ahead of your competitors. Download the Free PDF report

Some of the key companies that have been profiled in the report include: 

  • Agilent Technologies Inc.
  • Bio Rad Laboratories Inc.
  • Bruker Corp.
  • Danaher Corp.
  • General Electric Co.
  • Hamilton Co.
  • Hitachi Ltd.
  • IDEX Corp.
  • JASCO International Co. Ltd.
  • Merck KGaA
  • Orochem Technologies Inc.
  • Perkin Elmer Inc.
  • Restek Corp.
  • Sartorius AG
  • Shimadzu Corp.
  • Thermo Fisher Scientific Inc.
  • Tosoh Corp.
  • Trajan Scientific Australia Pty Ltd.
  • Waters Corp.
  • YMC Co. Ltd.

Market Research Overview 

The global life sciences tools and services market encompasses businesses involved in the research and development (R&D) of a range of product categories, including capital equipment, instruments, accessories, and consumables. These tools are utilized in the pharmaceutical and biotechnology industries for the production of innovative products, as well as in laboratory diagnosis of various diseases. Additionally, the market covers life sciences-related services, such as contract research, manufacturing, and sales. According to Technavio, the healthcare industry's total revenue is determined by the combined earnings of equipment, supply, pharmaceutical, biotechnology, and life science tools and services manufacturers. Factors driving growth in the life sciences tools and services market include the increasing global population aging, with the proportion of those over 60 years projected to rise significantly. - The High-Performance Liquid Chromatography (Hplc) Market is experiencing significant growth, fueled by the Increasing investments in healthcare sector. Businesses are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Market Research Analysis

High-Performance Liquid Chromatography (HPLC) is a chromatographic method widely used in various industries for the separation, identification, and quantification of pharmaceutical compounds, oligonucleotides, amino acids, and other biomolecules. HPLC instrumentation plays a crucial role in the drug approval process by ensuring the potency, identity, and purity of pharmaceuticals. In the pharmaceutical industry, HPLC is used for the analysis of viral proteins and antiviral treatments like Favipiravir. Clinical diagnostics also benefit from HPLC systems, as they enable the identification and quantification of diagnostic markers. HPLC is also used in the biotechnology industry for preparative purification of proteins, including vaccines and therapeutics. Two-dimensional liquid chromatography and Liquid Chromatography-Mass Spectrometry (LC-MS) are advanced HPLC techniques used for complex mixture analysis in forensic sciences, environmental impact assessment, food safety, and quality control in drug development. HPLC manufacturers continue to innovate, providing advanced systems and solutions for various applications in biochemistry, analytical chemistry, and biotechnology. HPLC is a versatile chromatographic method that continues to play a significant role in the development and quality control of pharmaceuticals, diagnostics, and biotechnology products.


Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Read News Read Less
Interested in this report?
Get your sample now!
Technavio